Update on rotavirus vaccine underperformance in low-to middle-income countries and next-generation vaccines
B Lee - Human vaccines & immunotherapeutics, 2021 - Taylor & Francis
In the decade since oral rotavirus vaccines (ORV) were recommended by the World Health
Organization for universal inclusion in all national immunization programs, significant yet …
Organization for universal inclusion in all national immunization programs, significant yet …
Vaccines for preventing rotavirus diarrhoea: vaccines in use
H Bergman, N Henschke, D Hungerford… - Cochrane Database …, 2021 - cochranelibrary.com
Background Rotavirus is a common cause of diarrhoea, diarrhoea‐related hospital
admissions, and diarrhoea‐related deaths worldwide. Rotavirus vaccines prequalified by …
admissions, and diarrhoea‐related deaths worldwide. Rotavirus vaccines prequalified by …
[HTML][HTML] Overview of the development, impacts, and challenges of live-attenuated oral rotavirus vaccines
OS Folorunso, OM Sebolai - Vaccines, 2020 - mdpi.com
Safety, efficacy, and cost-effectiveness are paramount to vaccine development. Following
the isolation of rotavirus particles in 1969 and its evidence as an aetiology of severe …
the isolation of rotavirus particles in 1969 and its evidence as an aetiology of severe …
Nanoparticles for mucosal vaccine delivery
Mucosal surfaces represent important routes of entry into the human body for the majority of
pathogens, and they constitute unique sites for targeted vaccine delivery. Nanoparticle …
pathogens, and they constitute unique sites for targeted vaccine delivery. Nanoparticle …
[HTML][HTML] Maternal antibody interference contributes to reduced rotavirus vaccine efficacy in developing countries
Rotavirus (RV) vaccine efficacy is significantly reduced in lower-and middle-income
countries (LMICs) compared to high-income countries. This review summarizes current …
countries (LMICs) compared to high-income countries. This review summarizes current …
[HTML][HTML] A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants
A fully liquid hexavalent containing Diphtheria (D), Tetanus (T) toxoids, whole cell Pertussis
(wP), Hepatitis B (Hep B), type 1, 2, 3 of inactivated poliovirus (IPV) and Haemophilus …
(wP), Hepatitis B (Hep B), type 1, 2, 3 of inactivated poliovirus (IPV) and Haemophilus …
Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL-Liquid) in Indian infants
Background A lyophilized bovine-human rotavirus reassortant pentavalent vaccine (BRV-
PV, Rotasiil®) was licensed in 2016. A liquid formulation of this vaccine (LBRV-PV, Rotasiil …
PV, Rotasiil®) was licensed in 2016. A liquid formulation of this vaccine (LBRV-PV, Rotasiil …
[HTML][HTML] Safety and immunogenicity of human neonatal RV3 rotavirus vaccine (Bio Farma) in adults, children, and neonates in Indonesia: Phase I Trial
Background Despite safe and effective WHO prequalified rotavirus vaccines, at least 84
million children remain unvaccinated. A birth dose schedule of the RV3-BB vaccine was …
million children remain unvaccinated. A birth dose schedule of the RV3-BB vaccine was …
Correlates of immune protection against human rotaviruses: natural infection and vaccination
T Latifi, A Kachooei, S Jalilvand, S Zafarian… - Archives of …, 2024 - Springer
Species A rotaviruses are the leading viral cause of acute gastroenteritis in children under 5
years of age worldwide. Despite progress in the characterization of the pathogenesis and …
years of age worldwide. Despite progress in the characterization of the pathogenesis and …
Anti-rotavirus antibody measurement in a rotavirus vaccine trial: Choice of vaccine antigen in immunoassays does matter
X Wang, DE Velasquez Portocarrero… - Human Vaccines & …, 2023 - Taylor & Francis
In a clinical trial of Bangladeshi infants who received three doses of RotaTeq (ages 6, 10,
and 14 weeks), we did a head-to-head assessment of two vaccine virus strains to measure …
and 14 weeks), we did a head-to-head assessment of two vaccine virus strains to measure …